N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide

C18H24N4O — CID 119799593

IUPACN-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide
SMILESO=C(CC1CCCN1)Nc1nc2ccccc2n1C1CCCC1
InChIInChI=1S/C18H24N4O/c23-17(12-13-6-5-11-19-13)21-18-20-15-9-3-4-10-16(15)22(18)14-7-1-2-8-14/h3-4,9-10,13-14,19H,1-2,5-8,11-12H2,(H,20,21,23)
InChIKeyYAPVTUMBZWCWJR-UHFFFAOYSA-N
MW312.42 g/mol
LogP3.23
Rot. Bonds4

About N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide

N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide (PubChem CID 119799593) has the molecular formula C18H24N4O and a molecular weight of 312.42 g/mol. Its IUPAC name is N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide.

Molecular Properties

Compound NameN-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide
PubChem CID119799593
Molecular FormulaC18H24N4O
Molecular Weight312.42 g/mol
Exact Mass312.20
IUPAC NameN-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide
SMILESO=C(CC1CCCN1)Nc1nc2ccccc2n1C1CCCC1
InChIInChI=1S/C18H24N4O/c23-17(12-13-6-5-11-19-13)21-18-20-15-9-3-4-10-16(15)22(18)14-7-1-2-8-14/h3-4,9-10,13-14,19H,1-2,5-8,11-12H2,(H,20,21,23)
InChIKeyYAPVTUMBZWCWJR-UHFFFAOYSA-N
XLogP3.23
TPSA58.95 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds4
Heavy Atoms23
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500312.42
LogP ≤ 53.23
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Analyze N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

N-[1-(4-methoxyphenyl)benzimidazol-2-yl]-2-pyrrolidin-2-ylacetamide;hydrochloride
CID 119800355
2-(4-acetamidophenyl)-N-(1-cyclopentylbenzimidazol-2-yl)acetamide
CID 136527419
3-amino-N-(1-cyclopentylbenzimidazol-2-yl)-3-phenylpropanamide;hydrochloride
CID 119951926
4-amino-N-(1-cyclohexylbenzimidazol-2-yl)pentanamide;hydrochloride
CID 120560614
N-(1-cyclopentylbenzimidazol-2-yl)-3-(1-methylpyrazol-4-yl)propanamide
CID 56794904
cis-(1S,2R)-N-[3-[(1-cyclohexylbenzimidazol-2-yl)amino]-3-oxopropyl]-2-methylcyclopropane-1-carboxamide
CID 94103495
4-(aminomethyl)-N-(1-cyclopentylbenzimidazol-2-yl)benzamide;hydrochloride
CID 119332720
N-(1-cyclohexylbenzimidazol-2-yl)-2-methyl-3-(methylamino)propanamide;hydrochloride
CID 119732157
N-[4-[(1-cyclopentylbenzimidazol-2-yl)amino]phenyl]-2-(dimethylamino)acetamide
CID 73051603
N-(1-cyclopentylbenzimidazol-2-yl)-5-methyl-1-piperidin-4-yltriazole-4-carboxamide;hydrochloride
CID 119799564
N-[1-(pyrrolidin-2-ylmethyl)benzimidazol-2-yl]pyridine-3-carboxamide
CID 90045404
N-(2-bromophenyl)-2-pyrrolidin-2-ylacetamide
CID 61371785

Frequently Asked Questions

What is the IUPAC name of N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide?
The IUPAC name of N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide (CID 119799593) is N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide.
What is the SMILES notation for N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide?
The canonical SMILES for N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide is O=C(CC1CCCN1)Nc1nc2ccccc2n1C1CCCC1.
What is the InChIKey of N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide?
The InChIKey is YAPVTUMBZWCWJR-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H24N4O/c23-17(12-13-6-5-11-19-13)21-18-20-15-9-3-4-10-16(15)22(18)14-7-1-2-8-14/h3-4,9-10,13-14,19H,1-2,5-8,11-12H2,(H,20,21,23).
What are the key properties of N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide?
N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide has a molecular weight of 312.42 g/mol, XLogP of 3.23, 4 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1-cyclopentylbenzimidazol-2-yl)-2-pyrrolidin-2-ylacetamide is sourced from PubChem (CID 119799593), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).